Amphetamine-induced changes in dopamine receptors in early postnatal rat brain

Developmental Neuroscience

Volumn 31, Issue 3, 2009, Pages 193-201

  Mukda, Sujira ^a   Kaewsuk, Sukit ^b   Ebadi, Manuchair ^c   Govitrapong, Piyarat ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

D Amphetamine; Dopamine D1 receptor; Dopamine D2 receptor; Postnatal rat; Tyrosine hydroxylase

Indexed keywords

DEXAMPHETAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EXPOSURE; FEMALE; GENETIC TRANSCRIPTION; MALE; NEWBORN; NEWBORN PERIOD; NONHUMAN; NUCLEUS ACCUMBENS; PERINATAL PERIOD; PREFRONTAL CORTEX; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; STIMULATION;

AMPHETAMINE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRAIN; DOPAMINE AGENTS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE;

EID: 67649117895     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000193395     Document Type: Article

References (47)

1. Bowyer JF, Frame LT, Clausing P, Nagamoto- Combs K, Osterhout CA, Sterling CR, Tank AW (1998): Long-term effects of amphetamine neurotoxicity on tyrosine hydroxylase mRNA and protein in aged rats. J Pharmacol Exp Ther 286: 1074-1085.
2. Bowyer JF, Tank AW, Newport GD, Slikker W Jr, Ali SF, Holson RR (1992): The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 260: 817-824.
3. Bozzi Y, Borrelli E (2006): Dopamine in neurotoxicity and neuroprotection: What do D2 receptors have to do with it? Trends Neurosci 29: 167-174.
4. Cooper JR, Bloom FE, Roth RH (2003): Dopamine; in Cooper JR, Bloom FE, Roth RH (eds): The Biochemical Basis of Neuropharmacology. New York, Oxford University Press, pp 225-270.
5. Cubells JF, Rayport S, Rajendran G, Sulzer D (1994): Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 14: 2260-2271.
6. De Vito MJ, Wagner GC (1989): Methamphetamine- induced neuronal damage: a possible role for free radicals. Neuropharmacology 28: 1145-1150.
7. Di Monte DA, Royland JE, Jakowec MW, Langston JW (1996): Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J Neurochem 67: 2443- 2450.
8. Eriksson M, Zetterstrom R (1994): Amphetamine addiction during pregnancy: 10-year follow-up. Acta Paediatr Suppl 404: 27-31.
9. Ferrucci M, Busceti CL, Falleni A, Giorgi FS, Ruggieri S, Fornai F (2006): Effects of methamphetamine on the cerebellar cortex: a preliminary study. Ann NY Acad Sci 1074: 149- 153.
10. Fumagalli F, Gainetdinov RR, Wang YM, Valenzano KJ, Miller GW, Caron MG (1999): Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci 19: 2424-2431.
11. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, Sibley DR (1990): D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250: 1429-1432.
12. Gibb JW, Johnson M, Hanson GR (1990): Neurochemical basis of neurotoxicity. Neurotoxicology 11: 317-321.
13. 11 C]raclopride positron emission tomography study in cats. Biol Psychiatry 55: 1188-1194.
14. Henry DJ, White FJ (1991): Repeated cocaine administration causes persistent enhancement of d1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther 258: 882-890.
15. Hotchkiss AJ, Gibb JW (1980): Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214: 257-262.
16. Itzhak Y, Ali SF (1996): The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem 67: 1770-1773.
17. Iversen L (2006): Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol 147(suppl 1):S82-S88.
18. Jackson DM, Westlind-Danielsson A (1994): Dopamine receptors: Molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 64: 291-370.
19. Kita T, Wagner GC, Philbert MA, King LA, Lowndes HE (1995): Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion. Mol Chem Neuropathol 24: 31-41.
20. Koda LY, Gibb JW (1973): Adrenal and striatal tyrosine hydroxylase activity after methamphetamine. J Pharmacol Exp Ther 185: 42- 48.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951): Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275.
22. Lucot JB, Wagner GC, Schuster CR, Seiden LS (1982): Decreased sensitivity of rat pups to long-lasting dopamine and serotonin depletions produced by methylamphetamine. Brain Res 247: 181-183.
23. Metzger RR, Haughey HM, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE (2000): Methamphetamine- induced rapid decrease in dopamine transporter function: Role of dopamine and hyperthermia. J Pharmacol Exp Ther 295: 1077-1085.
24. Murrin LC, Zeng W (1986): Postnatal ontogeny of dopamine D2 receptors in rat striatum. Biochem Pharmacol 35: 1159-1162.
25. Murrin LC, Zeng WY (1990): Ontogeny of dopamine D1 receptors in rat forebrain: a quantitative autoradiographic study. Brain Res Dev Brain Res 57: 7-13.
26. O'Dell SJ, Weihmuller FB, Marshall JF (1993): Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists. J Neurochem 60: 1792-1799.
27. Pardo JV, Creese I, Burt DR, Snyder SH (1977): Ontogenesis of dopamine receptor binding in the corpus striatum of the rat. Brain Res 125: 376-382.
28. Rao PA, Molinoff PB, Joyce JN (1991): Ontogeny of dopamine d1 and d2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Res Dev Brain Res 60: 161-177.
29. Ridley RM, Baker HF, Owen F, Cross AJ, Crow TJ (1982): Behavioural and biochemical effects of chronic amphetamine treatment in the vervet monkey. Psychopharmacology (Berl) 78: 245-251.
30. Rothman RB, Baumann MH (2003): Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479: 23-40.
31. Schambra UB, Duncan GE, Breese GR, Fornaretto MG, Caron MG, Fremeau RT Jr (1994): Ontogeny of D1a and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience 62: 65- 85.
32. Self DW, Barnhart WJ, Lehman DA, Nestler EJ (1996): Opposite modulation of cocaineseeking behavior by D1- and D2-like dopamine receptor agonists. Science 271: 1586- 1589.
33. Sibley DR, Monsma FJ, Jr., Shen Y (1993): Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol 35: 391-415.
34. Sorg BA, Davidson DL, Kalivas PW, Prasad BM (1997): Repeated daily cocaine alters subsequent cocaine- induced increase of extracellular dopamine in the medial prefrontal cortex. J Pharmacol Exp Ther 281: 54-61.
35. Tong J, Ross BM, Schmunk GA, Peretti FJ, Kalasinsky KS, Furukawa Y, Ang LC, Aiken SS, Wickham DJ, Kish SJ (2003): Decreased striatal dopamine d1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users. Am J Psychiatry 160: 896-903.
36. Unterwald EM, Fillmore J, Kreek MJ (1996): Chronic repeated cocaine administration increases dopamine d1 receptor-mediated signal transduction. Eur J Pharmacol 318: 31-35.
37. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N (2001): Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158: 2015-2021.
38. Volkow ND, Fowler JS, Wolf AP, et al. (1990): Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 147: 719-724.
39. Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R, Lieberman J, Pappas N (1997): Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry 154: 50-55.
40. Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, Pappas N, Shea C, Piscani K (1996): Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 20: 1594- 1598.
41. Wagner GC, Carelli RM, Jarvis MF (1986): Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion. Neuropharmacology 25: 559-561.
42. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J (1980): Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181: 151-160.
43. Wang JQ, Lau YS (2001): Dose-related alteration in nitric oxide synthase mRNA expression induced by amphetamine and the full D1 dopamine receptor agonist SKF-82958 in mouse striatum. Neurosci Lett 311: 5-8.
44. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ (1996): Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2: 699-703.
45. Worsley JN, Moszczynska A, Falardeau P, Kalasinsky KS, Schmunk G, Guttman M, Furukawa Y, Ang L, Adams V, Reiber G, Anthony RA, Wickham D, Kish SJ (2000): Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Mol Psychiatry 5: 664-672.
46. Xu SG, Prasad C, Smith DE (1999): Neurons exhibiting dopamine D2 receptor immunoreactivity in the substantia nigra of the mutant weaver mouse. Neuroscience 89: 191-207.
47. Zeng WY, Hyttel J, Murrin LC (1988): Ontogeny of dopamine D1 receptors in rat striatum. J Neurochem 50: 862- 867.